Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Matthew Schultz, Ph.D., and Amy White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related peripheral neuropathy is fairly common.
(00:31)
Would you share a little bit about yourself and your background?
(01:11)
Could you provide us with an overview of this particular peripheral neuropathy?
(03:09)
Can you share the background as to how your team learned about this condition and how you considered testing for it?
(04:42)
Would you explain what you saw when you performed the urine test on the first patient?
(05:26)
Were you able to test additional patients with this condition?
(06:09)
Could you expand on why this urine test is important?
(07:20)
How does a health care provider order urine testing for SORD deficiency?
(07:59)
How does this new SORD urine test complement the existing Mayo Clinic Laboratories test menu?
(08:55)
Could you summarize the benefits of ordering this SORD urine test at Mayo?